BBCS Announces FDA 510(k) Clearance for ABO Wheels

Share Article

FDA approves comprehensive mobile blood-collection application that can be used either at a collection facility or at a non-fixed site, regardless of connectivity to the main database, and is able to control multiple blood drives or remote events simultaneously.

BBCS Announces FDA 510(k) Clearance for ABO Wheels
ABO Wheels enables your staff to conduct world-class, paperless operations everywhere you desire to host blood drives.

Blood Bank Computer Systems, Inc. (BBCS) today announced that the Food and Drug Administration (FDA) has declared 510(k) clearance for its new ABO Wheels™ product, an essential part of the ABO Suite™. ABO Wheels is the second product in the ABO Suite to receive 510(k) clearance; the first one being ABO QuickPass™. ABO Wheels is a major breakthrough in blood bank software solutions. “This is another example of BBCS investing in new technology that makes us poised for the future,” says Beth Simon, CEO of BBCS.

ABO Wheels allows blood centers to conduct efficient, safe, paperless donor registration and screening at a reduced cost, and with increased staff and donor efficiencies. This comprehensive mobile blood-collection application can be used either at a collection facility or at a non-fixed site, regardless of connectivity to the main database, and is able to control multiple blood drives or remote events simultaneously. “ABO Wheels enables your staff to conduct world-class, paperless operations everywhere you desire to host blood drives,” says Brian Forbis, vice president of BBCS, who also explained that real-time entry of blood collection information and comprehensive data transfer to the BECS unlocks many opportunities for blood centers to escape the burden of double entry, or manual data entry. Ultimately, allowing blood to move through the supply chain at an excelled rate and a lower cost. Not to stop there, ABO Wheels also includes the ability to scan donor fingerprints – the latest in secure donor identification technology.

To receive a demonstration of ABO Wheels or ABO QuickPass, contact BBCS.

To view the Indications for Use and 510(k) Summary, visit the FDA’s website.

About BBCS
For over 30 years, Blood Bank Computer Systems, Inc. (BBCS) has been a dedicated partner to the blood banking industry. BBCS has chosen to remain privately owned to ensure that we can focus on fulfilling our commitments to our clients, the communities that they serve, and the industry. By establishing an annual BBCS CEO Summit, hosting annual meetings with our User Group, and participating in industry conferences we have built rich partnerships with our clients, vendors, and industry organizations.

These partnerships enable us to attain our goals of developing new innovations in blood bank automation that give our clients a competitive edge while providing lifesaving risk management solutions. Our clients experience many of the benefits of BECS system ownership without the hassles.

At BBCS, our Mission, Vision, and Values are deeply ingrained in everything we do, and we take pride in exemplifying these qualities every day. Click here to visit our website and learn more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jordan Ford
Blood Bank Computer Systems, Inc. (BBCS)

Visit website